29 March 2019

Interrad Makes Progress as it Prepares for Strategic Engagements

Interrad Medical's subcutaneous catheter securement device, SecurAcath, is rapidly becoming the standard of care in hospitals of NHS England and in leading hospitals around the world.

 

In June 2017 NICE issued guidance in favour of the use of SecurAcath.  In March 2018 by SecurAcath was selected for funding by NHS England’s ITP central procurement programme. Only four out of more than 250 applications were successful. This month SecurAcath was included in the 2019-20 Commissioning for Quality and Innovation framework (CQUIN). This is a system introduced in 2009 to make a proportion of healthcare providers' income conditional on demonstrating improvements in quality and innovation in specified areas of care. CQUIN’s 2019-20 publication specifies that SecurAcath is to be used as a replacement for adhesive securement devices, which include Bard Medical’s StatLock.

 

LGB acted as European placement agent in Interrad’s $7.5m equity fundraising in 2014 and in the company’s issuance of $7.5m loan notes in 2017/18. LGB is currently arranging the placement of a new series of notes and is advising the company on its engagement with strategic counterparties.  

Recent Articles

16 January 2020

Sale of Chairman Mentors International

LGB Corporate Finance has advised the shareholders of Chairman Mentors International Limited ("CMi") on its sale to MW&L Capital Partners Limited ("MW&L").

Read more

Deals

18 December 2019

SCISYS Group plc redeems medium term notes ahead of acquisition by CGI

All notes issued under the AIM quoted group’s medium term note (MTN) programme have now been redeemed at maturity ahead of the group’s acquisition by CGI.

Read more

News & Insights

26 November 2019

FCA Introduces Restrictions on the Distribution of Mini-bonds

You may have seen the reports of the FCA’s restrictions on the marketing of so-called speculative mini-bonds to retail investors in the wake of the LCF scandal, in which bonds, mass-marketed to retail investors, were used to lend on to Read more

News & Insights